DK1262177T3 - Medicinsk brug af thyromimetiske forbindelser til behandling af hårtab og kompositioner - Google Patents

Medicinsk brug af thyromimetiske forbindelser til behandling af hårtab og kompositioner

Info

Publication number
DK1262177T3
DK1262177T3 DK02253607T DK02253607T DK1262177T3 DK 1262177 T3 DK1262177 T3 DK 1262177T3 DK 02253607 T DK02253607 T DK 02253607T DK 02253607 T DK02253607 T DK 02253607T DK 1262177 T3 DK1262177 T3 DK 1262177T3
Authority
DK
Denmark
Prior art keywords
hair loss
compositions
treatment
medical use
thyromimetic compounds
Prior art date
Application number
DK02253607T
Other languages
Danish (da)
English (en)
Inventor
Yuan-Ching Chian
Peter Cornelius
Niall Stephen Doherty
Robert Lee Dow
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1262177T3 publication Critical patent/DK1262177T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966—Triazines or their condensed derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK02253607T 2001-05-31 2002-05-22 Medicinsk brug af thyromimetiske forbindelser til behandling af hårtab og kompositioner DK1262177T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29496201P 2001-05-31 2001-05-31

Publications (1)

Publication Number Publication Date
DK1262177T3 true DK1262177T3 (da) 2006-11-20

Family

ID=23135661

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02253607T DK1262177T3 (da) 2001-05-31 2002-05-22 Medicinsk brug af thyromimetiske forbindelser til behandling af hårtab og kompositioner

Country Status (19)

Country Link
US (2) US20030007941A1 (ja)
EP (1) EP1262177B1 (ja)
JP (1) JP4051230B2 (ja)
KR (1) KR100523503B1 (ja)
CN (1) CN1314393C (ja)
AT (1) ATE337009T1 (ja)
AU (1) AU784806B2 (ja)
CA (1) CA2387198C (ja)
CY (1) CY1105221T1 (ja)
DE (1) DE60214080T2 (ja)
DK (1) DK1262177T3 (ja)
ES (1) ES2267945T3 (ja)
HK (1) HK1049285B (ja)
HU (1) HUP0201834A3 (ja)
IL (2) IL149843A (ja)
PL (1) PL354216A1 (ja)
PT (1) PT1262177E (ja)
TW (1) TWI278313B (ja)
ZA (1) ZA200204189B (ja)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US7288257B2 (en) * 2002-05-23 2007-10-30 Michael Powell Diagnosis and treatment of human dormancy syndrome
US7485298B2 (en) 2002-05-23 2009-02-03 Michael Powell Diagnosis and treatment of human dormancy-related sequellae
US7622103B1 (en) * 2003-03-27 2009-11-24 Cielo Jill M Hair and scalp toxin remover composition and method of its making
CA2964111A1 (en) * 2005-03-29 2006-10-05 The Trustees Of The University Of Pennsylvania Methods for generating new hair folicles, treating baldness, and hair removal
US8147815B2 (en) * 2005-12-16 2012-04-03 Celmatrix Corporation Topical administration carrier composition and therapeutic formulations comprising same
CN102459185B (zh) 2009-04-20 2015-06-03 田边三菱制药株式会社 新型甲状腺激素β受体激动剂
AU2011338530B2 (en) 2010-12-06 2017-06-15 Follica, Inc. Methods for treating baldness and promoting hair growth
JP6156371B2 (ja) * 2012-06-08 2017-07-05 大正製薬株式会社 発毛組成物
EP2695611B1 (en) * 2012-08-06 2014-10-01 Dr. August Wolff GmbH & Co. KG Arzneimittel Eprotirome for use in the prevention and/or treatment of hair disorders and compositions thereof
US9827181B2 (en) 2013-06-05 2017-11-28 Industrial Technology Research Institute Method and pharmaceutical composition for hair growth
US9402876B2 (en) 2013-11-27 2016-08-02 Industrial Technology Research Institute Method and pharmaceutical composition for hair growth
CN104306168B (zh) * 2014-10-15 2017-05-24 华东师范大学 氮‑(4‑氯‑2,5‑二甲氧基苯基)‑5‑异丙基‑2‑甲氧基苯磺酰胺在促进毛发生长的应用
CA3030054A1 (en) 2016-07-15 2018-01-18 Institut Pasteur 5-hydroxytryptamine 1b receptor-stimulating agent for skin and/or hair repair
US9962444B2 (en) 2016-09-27 2018-05-08 Shane Malek Pharmacokinetically extended action topical hair growth formulation, and administration method
CN111094554A (zh) 2017-09-14 2020-05-01 国立研究开发法人理化学研究所 视网膜组织的制备方法
CN108727344A (zh) * 2018-05-14 2018-11-02 嘉兴特科罗生物科技有限公司 一种化合物及其合成方法和应用
US11766392B2 (en) * 2018-10-05 2023-09-26 Jupiter Wellness, Inc. Minoxidil adjuvant therapies
US11628132B2 (en) 2018-10-05 2023-04-18 Jupiter Wellness, Inc. Minoxidil adjuvant therapies
JPWO2020184720A1 (ja) 2019-03-13 2020-09-17
EP3965884A1 (en) 2019-05-08 2022-03-16 Aligos Therapeutics, Inc. Modulators of thr-beta and methods of use thereof
IL294494A (en) 2020-01-13 2022-09-01 Eccogene Shanghai Co Ltd Triazinones are transduced as thyroid hormone receptor agonists
US20230312527A1 (en) * 2020-08-19 2023-10-05 Chengdu Fanxi Biopharma Co., Ltd. Cyanotriazine derivative, preparation method therefor, and application thereof
US20230313133A1 (en) 2020-09-11 2023-10-05 Riken Complex Containing Neural Retina-Containing Cell Aggregates and Matrix, and Method for Manufacturing Same
EP4201428A1 (en) 2020-09-11 2023-06-28 Sumitomo Pharma Co., Ltd. Medium for tissue for transplantation
AU2022390766A1 (en) 2021-11-19 2024-06-20 Riken Production method for sheet-like retinal tissue
CN116327765A (zh) * 2023-03-27 2023-06-27 广州许愿树毛发医学科技有限公司 莲心碱类化合物作为β2-肾上腺素受体阻断剂的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0137234B1 (en) * 1983-08-17 1990-10-10 The Wellcome Foundation Limited Physiologically active compositions
JPS61165311A (ja) * 1985-01-14 1986-07-26 Takeo Kinji 養毛化粧料
US5061798A (en) * 1985-01-18 1991-10-29 Smith Kline & French Laboratories, Ltd. Benzyl pyridyl and pyridazinyl compounds
US5284971A (en) * 1992-07-16 1994-02-08 Syntex (U.S.A.) Inc. 4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents
CA2159985C (en) * 1993-04-20 1999-07-13 Raphael Warren Methods of using hesperetin for sebum control and treatment of acne
TW382595B (en) * 1993-10-15 2000-02-21 Merck & Co Inc Pharmaceutical composition for use in arresting and reversing androgenic alopecia
EP0970683A4 (en) * 1997-01-23 2005-08-24 Taisho Pharmaceutical Co Ltd PERSISTENT CAPILLARY TONIC
SK12102001A3 (sk) * 1999-03-01 2002-10-08 Pfizer Products Inc. Oxámové kyseliny a ich deriváty ako ligandy tyreoidného receptora
CO5160290A1 (es) * 1999-03-29 2002-05-30 Novartis Ag Derivados de acido fenoxifeniloxamico sustituido .
EP1185232A1 (en) * 1999-06-01 2002-03-13 University Of Texas Southwestern Medical Center Method of treating hair loss using sulfonyl thyromimetic compounds
MXPA01012491A (es) * 1999-06-01 2002-07-02 Univ Texas Southwestern Med Ct Compuestos de eter biarilico sustituido.
AU3611500A (en) * 1999-06-01 2000-12-18 University Of Texas Southwestern Medical Center, The Sulfur-containing thyroxane derivatives and their use as hair growth promotors
EP1194422A1 (en) * 1999-06-01 2002-04-10 University Of Texas Southwestern Medical Center Biaryl compounds
MXPA01012493A (es) * 1999-06-01 2003-09-10 Univ Texas Southwestern Med Ct Metodo para tratar la perdida capilar con el uso de derivados de eter difenilico.
ATE297905T1 (de) * 1999-09-30 2005-07-15 Pfizer Prod Inc 6-azauracilderivate als liganden der thyroidrezeptoren
WO2001070687A1 (de) * 2000-03-23 2001-09-27 Bayer Aktiengesellschaft Indole zur behandlung von krankheiten die mit schilddrüsenhormonen behandeln werden können
AU2002223626A1 (en) * 2000-10-20 2002-04-29 Novartis Ag Combinations of a thyromimetic compound and a statin

Also Published As

Publication number Publication date
CN1389203A (zh) 2003-01-08
CY1105221T1 (el) 2010-03-03
IL149843A (en) 2008-11-26
JP2002370978A (ja) 2002-12-24
KR20020092247A (ko) 2002-12-11
ES2267945T3 (es) 2007-03-16
HUP0201834A2 (hu) 2003-01-28
CA2387198C (en) 2007-02-13
US20030007941A1 (en) 2003-01-09
HK1049285A1 (en) 2003-05-09
EP1262177B1 (en) 2006-08-23
AU4446202A (en) 2002-12-05
AU784806B2 (en) 2006-06-29
TWI278313B (en) 2007-04-11
EP1262177A3 (en) 2003-09-03
DE60214080D1 (de) 2006-10-05
IL188110A0 (en) 2008-03-20
ZA200204189B (en) 2003-11-27
PL354216A1 (en) 2002-12-02
IL149843A0 (en) 2002-11-10
DE60214080T2 (de) 2007-01-04
HUP0201834A3 (en) 2004-03-29
CA2387198A1 (en) 2002-11-30
HK1049285B (zh) 2007-08-24
CN1314393C (zh) 2007-05-09
HU0201834D0 (ja) 2002-08-28
EP1262177A2 (en) 2002-12-04
PT1262177E (pt) 2006-12-29
US20080125433A1 (en) 2008-05-29
JP4051230B2 (ja) 2008-02-20
KR100523503B1 (ko) 2005-10-26
ATE337009T1 (de) 2006-09-15

Similar Documents

Publication Publication Date Title
DK1262177T3 (da) Medicinsk brug af thyromimetiske forbindelser til behandling af hårtab og kompositioner
BR0211251B1 (pt) composição para o tratamento de cabelo e/ou couro cabeludo.
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
BR9909668A (pt) Uso de compostos de organofósforo para o tratamento terapêutico e profilático de infecções
BR0202519B1 (pt) métodos para tratamento de material de madeira e para tratamento microbicida de material de madeira.
DK1212422T3 (da) Humane CTLA-4-antistoffer og anvendelserne deraf
DE60133029D1 (de) Mittel zur prävention oder behandlung von psoriasi
ATE514430T1 (de) Behandlung des alpha-galactosidase a mangels
DE50212701D1 (de) Bestrahlungsanordnung zur behandlung von akne und aknenarben
ATE362374T1 (de) Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust
ATE466585T1 (de) Präparationen grampositiver bakterien zur behandlung von krankheiten mit immunfehlregulation
BR0201862A (pt) Composições e métodos para tratar ou prevenir convulsões ou ataques apoplécticos
NO20053903D0 (no) Nukleotidlipidesterderivater.
BR0213408A (pt) Métodos de prevenção e de tratamento de infecção por flavivìrus em animais
DE50114605D1 (de) No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
DE60206289D1 (de) Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne
NO20062229L (no) Middel og fremgangsmate for a behandle cancer omfattende strontium, aminosyre(r) og mineralagent(er)
DE60125212D1 (de) Verwendung von Aivlosin zur Behandlung und Prevention der Lawsonia-Infektionen in Schweinen.
BR0111785A (pt) Composições e métodos para tratamento de candidìase
DE69827814D1 (de) 8a-AZALIDEN ALS ANTIMIKROBIELLE AGENTEN
ATE420852T1 (de) Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen
DE60334289D1 (de) Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen
AU9683401A (en) Flea peritrophin nucleic acid molecules, proteins and uses thereof
DE60229502D1 (de) Verfahren und mittel zur behandlung von krebs bei hunden
ITGE20040064A1 (it) Metodo per l'applicazione di campo elettromagnetico per il trattamento di esseri umani,animali o piante.